University College London

University College London scientists led a study suggesting memory problems in Alzheimer s disease may be caused by a breakdown in how the brain replays recent experiences during periods of rest. This research could eventually help guide better treatments and earlier diagnosis of Alzheimer s disease.

University College London contributed significantly to the study, with Professor Mika Kivimäki leading the research. Their involvement underscores the collaborative nature of this important medical research.

University College London co-led the study, contributing significantly to the understanding of GLP-1 drug mechanisms in heart attack recovery and bolstering its research standing.

University College London is represented by Paul Ekins, a keynote speaker, contributing academic expertise to the conference.

University College London's research estimated that 1.6 million adults in England, Wales, and Scotland used GLP-1s between early 2024 and early 2025 for weight loss, providing context for the United Kingdom===Medicines and Healthcare products Regulatory Agency's warning.